Recursion Pharmaceuticals Inc Clas (RXRX)

Other Income/Expenses (Net)

$20.54M

TTM · Period ending: · USD

RXRX logo

RXRX Other Income/Expenses (Net)

Latest reported$20.54M
RXRX TTM Other Income/Expenses (Net) (-$2.39M → $20.54M)
High-resolution chart · PNG

RXRX other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Recursion Pharmaceuticals Inc Clas Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
20,543,000
20,911,000
3,237,000
7,874,000
601,000
-1,249,000
14,216,000
11,219,000
15,073,000
17,581,000
17,931,000
19,549,000
15,144,000
10,787,000
6,251,000
2,788,000
-366,000
-3,469,000
-3,704,000
-3,916,000
-4,289,000
-2,543,000
-2,391,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.